8-K
filed May 7, 2026, 7:59 PM ET
ticker SPT
CIK 0001517375
earnings
confidence high
sentiment positive
materiality 0.75
Sprout Social Q1 revenue $121.5M (+11% YoY), non-GAAP EPS $0.23, authorizes $50M buyback
Sprout Social, Inc.
2026-Q1 EPS reported
-$0.11
revenue$121,497,000
- Revenue $121.5M, +11% YoY; GAAP operating loss ($5.8M) improved from ($11.2M).
- Non-GAAP operating income $14.1M vs $12.5M; Non-GAAP EPS $0.23 vs $0.22.
- Non-GAAP free cash flow $24.7M, up from $19.5M; cash $111.6M.
- Board authorized $50M share repurchase program for Class A common stock.
- $30K+ ARR customer contribution grew 21% YoY.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001517375-26-000034
- form_type
- 8-K
- ticker
- SPT
- cik
- 0001517375
- company_name
- Sprout Social, Inc.
- filed_at
- 2026-05-07T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:32.405073+00:00
- generated_at
- 2026-05-14T21:37:15.445963+00:00
- sec_items
- ["2.02", "7.01", "8.01", "9.01"]
- event_type
- earnings
- sentiment
- positive
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001517375-26-000034
- json_url
- https://secwatch.observer/filing/0001517375-26-000034.json
- markdown_url
- https://secwatch.observer/filing/0001517375-26-000034.md
- text_url
- https://secwatch.observer/filing/0001517375-26-000034.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1517375/000151737526000034/0001517375-26-000034-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1517375/000151737526000034/spt-20260507.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SNDA
Sonida Senior Living reports Q1 net loss of $41.2M; revenue up 37% on CHP acquisition
SONIDA SENIOR LIVING, INC.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
same event type: earnings
similar materiality
This filing
with an initial authorization of $50 million, which highlights our disciplined approach to capital allocation.” First Quarter 2026 Financial Highlights Revenue ● Revenue was $121.5 million, up 11% compared to the first quarter of 2025. ● Total remaining performance obligations (RPO) of $395.3 million as of March 31, 2026, up 10% year-over-year. ● Current
Comparable filing
Sonida Senior Living Announces First Quarter 2026 Results DALLAS, Texas – May 11, 2026 – Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the first quarter ended March 31, 2026.
Filing page
SEC filing
ACH
Accendra Health Q1 revenue $627.8M, adj. EBITDA $58.4M; >$1.5B debt optimization
ACCENDRA HEALTH INC/VA/
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
This filing
with an initial authorization of $50 million, which highlights our disciplined approach to capital allocation.” First Quarter 2026 Financial Highlights Revenue ● Revenue was $121.5 million, up 11% compared to the first quarter of 2025. ● Total remaining performance obligations (RPO) of $395.3 million as of March 31, 2026, up 10% year-over-year. ● Current
Comparable filing
Commission this morning. Details on First Quarter 2026 Results First Quarter Results (1) ($ in millions, except per share data) 1Q26 1Q25 Net Revenue $ 627.8 $ 673.9 Loss from continuing operations, net of tax, GAAP $ (6.5) $ (3.8) Adj. net (loss) income from continuing operations, Non-GAAP $ (3.1) $ 23.2
Filing page
SEC filing
LQDA
Liquidia Q1 2026 net income $53M vs $38M loss YoY; YUTREPIA sales $130M
Liquidia Corp
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
same event type: earnings
similar materiality
This filing
with an initial authorization of $50 million, which highlights our disciplined approach to capital allocation.” First Quarter 2026 Financial Highlights Revenue ● Revenue was $121.5 million, up 11% compared to the first quarter of 2025. ● Total remaining performance obligations (RPO) of $395.3 million as of March 31, 2026, up 10% year-over-year. ● Current
Comparable filing
First Quarter 2026 Financial Results YUTREPIA sales led to the company’s third consecutive quarter of profitability with net income of $52.9 million and positive non-GAAP adjusted EBITDA of $71.2 million in the first quarter of 2026. Cash and cash equivalents totaled $222.8 million as of March 31, 2026, compared to $190.7 million as of December 31, 2025. Product sales, net, were $129.9 million for the three months ended March 31, 2026.
Filing page
SEC filing
FSK
FSK posts Q1 GAAP loss of $1.57/sh, NAV falls to $18.83; announces $150M preferred, tender, buyback
FS KKR Capital Corp
May 11, 2026, 7:59 PM ET
earnings
Items 1.01, 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
This filing
with an initial authorization of $50 million, which highlights our disciplined approach to capital allocation.” First Quarter 2026 Financial Highlights Revenue ● Revenue was $121.5 million, up 11% compared to the first quarter of 2025. ● Total remaining performance obligations (RPO) of $395.3 million as of March 31, 2026, up 10% year-over-year. ● Current
Comparable filing
Earnings (Loss) per share of ($1.57), compared to Earnings (Loss) per share of ($0.41) for the quarter ended December 31, 2025
Filing page
SEC filing
SBH
Sally Beauty Q2 sales up 2.3%; GAAP EPS $0.43 beats year-ago $0.38; guidance range narrowed
Sally Beauty Holdings, Inc.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
This filing
with an initial authorization of $50 million, which highlights our disciplined approach to capital allocation.” First Quarter 2026 Financial Highlights Revenue ● Revenue was $121.5 million, up 11% compared to the first quarter of 2025. ● Total remaining performance obligations (RPO) of $395.3 million as of March 31, 2026, up 10% year-over-year. ● Current
Comparable filing
Consolidated net sales of $903 million, an increase of 2.3% compared to the prior year; • Consolidated comparable sales growth of 1.3%; • Global e-commerce sales increased 13% to $108 million, representing 12% of net sales; • GAAP gross margin expansion of 70 basis points to 52.7%; • Adjusted Gross Margin expansion of 80 basis points to 52.8%; • GAAP selling, general and administrative expenses of $404 million, an increase of $14 million compared to the prior year; • Adjusted Selling, General and Administrative Expenses of $404 million, an increase of $20 million compared to the prior year; • GAAP operating earnings of $72 million and GAAP operating margin of 8.0%; • Adjusted Operating Earnings of $73 million and Adjusted Operating Margin of 8.1%; • GAAP diluted net earnings per share of $0.43, an increase of 13% compared to the prior year;
Filing page
SEC filing
APC
ARKO Petroleum Q1 net income $8.1M ($4.5M), Adj. EBITDA $36.4M ($30.9M); completes IPO
ARKO Petroleum Corp.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
This filing
with an initial authorization of $50 million, which highlights our disciplined approach to capital allocation.” First Quarter 2026 Financial Highlights Revenue ● Revenue was $121.5 million, up 11% compared to the first quarter of 2025. ● Total remaining performance obligations (RPO) of $395.3 million as of March 31, 2026, up 10% year-over-year. ● Current
Comparable filing
announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Key Highlights (vs. Year-Ago Period) 1,2 • Net income for the quarter increased to $8.1 million compared to $4.5 million. • Adjusted EBITDA for the quarter increased to $36.4 million compared to $30.9 million. • Net cash provided by operating activities for the quarter was
Filing page
SEC filing
LXEO
Lexeo Therapeutics Q1 net loss $20.2M; cash $227.6M; LX2006 pivotal trial protocol submitted to FDA
Lexeo Therapeutics, Inc.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 8.01, 9.01
same event type: earnings
similar materiality
This filing
with an initial authorization of $50 million, which highlights our disciplined approach to capital allocation.” First Quarter 2026 Financial Highlights Revenue ● Revenue was $121.5 million, up 11% compared to the first quarter of 2025. ● Total remaining performance obligations (RPO) of $395.3 million as of March 31, 2026, up 10% year-over-year. ● Current
Comparable filing
Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights
Filing page
SEC filing
NESR
NESR Q1 revenue $404.6M (+33.5% YoY); net income $23.8M (+129%); EPS $0.23
National Energy Services Reunited Corp.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
This filing
with an initial authorization of $50 million, which highlights our disciplined approach to capital allocation.” First Quarter 2026 Financial Highlights Revenue ● Revenue was $121.5 million, up 11% compared to the first quarter of 2025. ● Total remaining performance obligations (RPO) of $395.3 million as of March 31, 2026, up 10% year-over-year. ● Current
Comparable filing
National Energy Services Reunited Corp. Reports First Quarter 2026 Financial Results ● Revenue for the quarter ended March 31, 2026, is $404.6 million, reflecting an increase of 33.5% year-over-year and 1.6% sequentially ● Net income for the quarter ended March 31, 2026, is $23.8 million, improving 205.4% sequentially and 129.3% year-over-year ● Diluted Earnings per Share (EPS) for the three months ended March 31, 2026 is $0.23, representing an increase of 109.1% year-over-year and 201.3% sequentially
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.